National Peroxide restates FY26 results; Q1 FY27 PAT drops 87%

Results RestatedEmphasis Of MatterPat NegativeRevenue DeclineResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+5.1%Reaction day

₹582.50

prior close

₹612.05

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.4%+4.7% vs market

Commodity Chemicals peers, median of 54sector-0.6%+5.6% vs sector

On the reaction day the stock moved 4.7 pts more than Nifty Microcap 250 and 5.6 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.0

10m

-0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+5.1+0.4+4.7-0.6+5.6

Next day

+10.3+0.5+9.8-0.9+11.2

+15.8+0.6+15.2-0.5+16.3

+11.8+0.7+11.0-1.5+13.2

+9.4+1.1+8.3-2.1+11.5

+9.7+0.5+9.2-2.6+12.3

+6.6+1.3+5.3-2.2+8.9

15d

+4.9+0.5+4.4-1.8+6.7

+3.3-0.8+4.2-0.8+4.2

+0.6-0.9+1.6-0.5+1.1

—————

UpDownMarket · Nifty Microcap 250Sector · Commodity Chemicals peers, median of 54Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

NPL restated FY26 results after an ERP error understated natural gas costs by about Rs. 694.63 lakhs. FY26 PAT fell to Rs. 922.96 lakhs from Rs. 1,103.71 lakhs, and Q4 FY26 swung to a loss of Rs. 468.16 lakhs. Auditors issued an unmodified opinion with emphasis of matter. Q1 FY27 revenue dropped to Rs. 666.55 lakhs from Rs. 856.83 lakhs, with PAT crashing to Rs. 89.03 lakhs from Rs. 660.89 lakhs. Final dividend of Rs. 7 per share unchanged. AGM on September 29, 2026.

Likely market impact

Restated FY26 shows lower profit and Q4 turned to a loss. Q1 FY27 weakness and ERP error disclosure may weigh on the stock.